Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Increased by Dakota Wealth Management

Dakota Wealth Management boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 157.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,026 shares of the medical equipment provider's stock after purchasing an additional 14,074 shares during the quarter. Dakota Wealth Management's holdings in Intuitive Surgical were worth $11,404,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $2,401,493,000. GAMMA Investing LLC lifted its position in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares in the last quarter. Capital Research Global Investors lifted its position in shares of Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after acquiring an additional 494,496 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after acquiring an additional 360,591 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG traded up $1.32 on Thursday, reaching $513.96. The company's stock had a trading volume of 875,805 shares, compared to its average volume of 1,682,723. The stock has a market cap of $184.21 billion, a price-to-earnings ratio of 75.34, a price-to-earnings-growth ratio of 5.43 and a beta of 1.64. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The business's 50 day moving average is $536.71 and its 200 day moving average is $536.21.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business posted $1.50 earnings per share. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Evercore ISI upped their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $592.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.